OpenText and Knight Therapeutics were among the limited partners as Canada-based Teralys reached the final close of its Teralys Capital Innovation Fund.
Canada-based venture capital fund manager Teralys Capital has closed a C$375m ($290m) fund of funds having secured capital from limited partners including pharmaceutical company Knight Therapeutics and enterprise software provider OpenText.
Founded in 2009, Teralys oversees C$1.6bn of assets spread across four funds. The newly closed Teralys Capital Innovation Fund was set up as part of the Canadian government’s Canada’s Venture Capital Action Plan and was oversubscribed.
The fund’s other LPs include Caisse de dépôt et placement du Québec, Fonds…
